Stay updated on Flotetuzumab in PIF/ER AML Clinical Trial

Sign up to get notified when there's something new on the Flotetuzumab in PIF/ER AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Flotetuzumab in PIF/ER AML Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A government-funding notice was added about the NIH Clinical Center's status, and the page revision version updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-04T10:29:46.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Show glossary is now available; Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0 are added, while Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-28T06:33:07.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.3 to v3.3.4.
    Difference
    0.0%
    Check dated 2026-01-14T02:42:04.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Introduced a consolidated Locations section listing states and District of Columbia (California, District of Columbia, Florida, Georgia, Illinois, Maryland, Michigan, Missouri, New York, North Carolina, Ohio, Oregon, Tennessee, Texas, Washington, Wisconsin) and removed the separate per-state location pages.
    Difference
    1%
    Check dated 2025-12-23T17:29:34.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    Editorial changes were made to the Publications section: a new note clarifies that PubMed-listed publications are automatically filled, and the page’s revision tag was updated to v3.3.2; a corresponding older note about PubMed-derived publications was removed and replaced (Revision: v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:37:55.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    A government funding status notice banner was removed from the page, and this does not affect the study's details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-18T06:54:31.000Z thumbnail image

Stay in the know with updates to Flotetuzumab in PIF/ER AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Flotetuzumab in PIF/ER AML Clinical Trial page.